Search
Search Results
##search.searchResults.foundPlural##
-
“IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”
3991PDF: 1050HTML: 3590Untitled: 177Cneo. Fig.1: 113Untitled: 104Untitled: 126Untitled: 131 -
TOLL-LIKE RECEPTORS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2577PDF: 860HTML: 17469Fig1 Caligaris: 171Fig.2 Caliga: 203 -
COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.
2261PDF: 933HTML: 301 -
THERAPY-RELATED MYELOID NEOPLASMS: CONSIDERATIONS FOR PATIENTS’ CLINICAL EVALUATION. Clinical Evaluation of T-AML
1609PDF: 806HTML: 164 -
SOCIOECONOMIC STATUS IS GLOBALLY A PROGNOSTIC FACTOR FOR OVERALL SURVIVAL OF MULTIPLE MYELOMA PATIENTS; SYNTHESIS OF STUDIES AND REVIEW OF THE LITERATURE SES as prognostic factor for myeloma survival
2026PDF: 821HTML: 211 -
THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.
4038PDF: 1150HTML: 1935Fig.1: 218Fig. 2: 111Table 1: 201Table2: 219Table 3: 199 -
Acquired Hemophilia A successfully treated with rituximab
1928PDF: 1142HTML: 1457Figure 1: 175 -
THERAPEUTIC VALUE OF COMBINED THERAPY WITH DEFERASIROX AND SILYMARIN ON IRON OVERLOAD IN CHILDREN WITH BETA THALASSEMIA
2604PDF: 829HTML: 14949Therapeutic Value of Combined Therapy with Deferasirox and Silymarin on Iron Overload in Children with Beta Thalassemia: 305 -
I INCREASED RISK OF LYMPHOMA IN MEN INFECTED WITH TUBERCULOSIS
1138PDF: 473HTML: 317 -
VON WILLEBRAND FACTOR, ANGIODYSPLASIA AND ANGIOGENESIS
3739PDF: 1561HTML: 8031Randi Fig: 181 -
The Outcome of Six Patients with COVID-19 Infection and Multiple Myeloma. A Case Series and Literature Review COVID-19 in Multiple Myeloma patients
969PDF: 361HTML: 193 -
SICKLE CELL ANAEMIA AND MALARIA
11422PDF: 6986HTML: 23853Figures Malaria and SCK: 210 -
-
ASSOCIATION BETWEEN PRE-ADMISSION 48-HOUR FEVER BURDEN AND OUTCOMES IN PEDIATRIC MYCOPLASMA PNEUMONIAE INFECTION PRE-ADMISSION 48-HOUR FEVER BURDEN AND OUTCOMES IN PEDIATRIC MYCOPLASMA PNEUMONIAE
138PDF: 161Suppl. Files: 30HTML: 20 -
TDT Positive High-Grade Lymphoma with Myc, BCL2 And BCL6 Rearrangements: a Review of Diagnosis and Treatment TDT POSITIVE HIGH-GRADE LYMPHOMA WITH MYC, BCL2 AND BCL6 REARRANGEMENTS.
1715PDF: 766HTML: 504 -
MYELODYSPLASTIC SYNDROMES AND IRON CHELATION THERAPY
3376PDF: 1292HTML: 1861Fig.1: 199Fig. 2: 207 -
Microangiopathic Anemia of Acute Brucellosis – is it a True TTP?
1175PDF: 789HTML: 1770 -
EFFICACY OF VENETOCLAX COMBINED WITH AZACITIDINE IN ELDERLY PATIENTS WITH RELAPSED ACUTE MYELOID LEUKEMIA
1455PDF: 761Suppl. Files: 323Html: 135 -
JUSTIFICATION OF UNIVERSAL IRON SUPPLEMENTATION FOR INFANTS 6-12 MONTHS IN REGIONS WITH A HIGH PREVALENCE OF THALASSEMIA Iron Supplementation for Infants 6-12 months in Regions with a High Prevalence of Thalassemia
2084PDF: 607Suppl. Files: 283HTML: 169 -
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE
1243PDF: 473HTML: 18568Figure 1: 168Figure 2: 150Figure 3: 167Figure 4: 204Figure 5: 176 -
DISTRIBUTION OF DNA DAMAGE REPAIR GENE POLYMORPHISM hOGG1, XRCC1 and p53 AMONG SICKLE CELL DISEASE PATIENTS IN INDIA
1533PDF: 784HTML: 1475Table Genotype and allele frequencies of hOGG1 codon 326 Ser>Cys and p53 72Arg>Pro polymorphisms among SCD patients and control group: 179 -
MOLECULAR PATHOGENESIS OF SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA
2834PDF: 847HTML: 6518Untitled: 226Untitled: 189Untitled: 203Untitled: 210 -
Simultaneous dual pathology in lymph node
1648PDF: 691HTML: 7692Simultaneous dual pathology in lymph node: 173Simultaneous dual pathology in lymph node: 171Simultaneous dual pathology in lymph node: 149Simultaneous dual pathology in lymph node: 188Simultaneous dual pathology in lymph node: 173 -
ALLOGENEIC TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA
1365PDF: 755HTML: 942 -
NPM1 MUTATED, BCR-ABL1 POSITIVE MYELOID NEOPLASMS: REVIEW OF LITERATURE NPM1 mutated, BCR-ABL1 positive myeloid neoplasms
1657PDF: 1173HTML: 201 -
APPROACHING THE TARGET: THE PATH TOWARDS AN EFFECTIVE MALARIA VACCINE
2549PDF: 962HTML: 15105 -
DECREASED CD10 EXPRESSION IN THE BONE MARROW NEUTROPHILS OF HIV POSITIVE PATIENTS
1239PDF: 865HTML: 1116Coverletter: 192







